University of Minnesota president Rebecca Cunningham is drawing on her experience as an emergency physician in this ...

The Food and Drug Administration on Monday named George Tidmarsh, a longtime biotech executive who has a background in ...

The number of basic science papers published by NIH grant recipients has been falling since 2013, when the agency’s budget ...

The crisis over Sarepta Therapeutics' Duchenne therapy offers a valuable lesson: Listening to critics, and responding with ...

CASP, the protein structure prediction contest that launched DeepMind’s Alphafold to international fame and a Nobel Prize, ...

Since the Affordable Care Act went into effect, health insurance companies have been a favorite on Wall Street. More people ...

As mothers of children with this disease, we have wept helplessly in recent months as friends — fellow members of a club we ...

Sarepta Therapeutics refused a FDA request to halt shipments of Elevidys, its gene therapy for Duchenne muscular dystrophy ...

On Friday, Congressional Republicans passed legislation to take back money they’d already appropriated this year, enacting steep cuts to foreign aid and public broadcasting. It doesn’t sound like it’s ...

Omega Funds, the biotech VC firm founded by brash investor Otello Stampacchia, has raised nearly $650 million to invest in ...

Alkermes’ investigational drug helped people with a type of narcolepsy stay awake during the day in a mid-stage trial.

You know you’re going to die, right?” When Joy Lisi Rankin’s mother decided not to treat her breast cancer, doctors were ...